Miller Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Miller Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$439K	Hold	3,435	–	–	0.04%	73
2025 Q4	$419K	Hold	3,435	–	–	0.04%	78
2025 Q3	$344K	Hold	3,435	–	–	0.03%	89
2025 Q2	$285K	Hold	3,435	–	–	0.03%	89
2025 Q1	$279K	Hold	3,435	–	–	0.03%	90
2024 Q4	$309K	Hold	3,435	–	–	0.03%	90
2024 Q3	$339K	Sell	3,435 -3,140	-48%	-$309K	0.04%	89
2024 Q2	$610K	Hold	6,575	–	–	0.07%	75
2024 Q1	$624K	Hold	6,575	–	–	0.08%	78
2023 Q4	$587K	Hold	6,575	–	–	0.08%	79
2023 Q3	$480K	Hold	6,575	–	–	0.08%	75
2023 Q2	$547K	Hold	6,575	–	–	0.08%	74
2023 Q1	$501K	Hold	6,575	–	–	0.08%	74
2022 Q4	$546K	Hold	6,575	–	–	0.09%	72
2022 Q3	$522K	Hold	6,575	–	–	0.11%	65
2022 Q2	$488K	Hold	6,575	–	–	0.1%	67
2022 Q1	$591K	Sell	6,575 -386	-6%	-$35.6K	0.09%	63
2021 Q4	$779K	Buy	6,961 +3,573	+105%	+$431K	0.11%	58
2021 Q3	$426K	Sell	3,388 -4,688	-58%	-$604K	0.07%	70
2021 Q2	$1.09M	Hold	8,076	–	–	0.19%	45
2021 Q1	$1.1M	Hold	8,076	–	–	0.2%	44
2020 Q4	$1.14M	Hold	8,076	–	–	0.21%	42
2020 Q3	$900K	Hold	8,076	–	–	0.22%	41
2020 Q2	$904K	Buy	8,076 +1,300	+19%	+$128K	0.27%	40
2020 Q1	$525K	Hold	6,776	–	–	0.17%	48
2019 Q4	$644K	Hold	6,776	–	–	0.14%	50
2019 Q3	$517K	Hold	6,776	–	–	0.12%	54
2019 Q2	$594K	Hold	6,776	–	–	0.14%	52
2019 Q1	$613K	Sell	6,776 -3,388	-33%	-$288K	0.16%	50
2018 Q4	$729K	Hold	10,164	–	–	0.21%	43
2018 Q3	$974K	Hold	10,164	–	–	0.3%	40
2018 Q2	$968K	Buy	+10,164	New	+$934K	0.29%	41

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Miller Investment Management's XBI Position: Q1 2026 in Review

Miller Investment Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 3,435 shares worth $439K. The position accounts for 0.04% of the portfolio, ranked #73.

Miller Investment Management first reported a position in XBI in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.14M in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Miller Investment Management held 3,435 shares of State Street SPDR S&P Biotech ETF worth $439K as of Q1 2026.
Miller Investment Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.04% of Miller Investment Management's portfolio in Q1 2026, its #73 holding.
Miller Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 32 quarters since.
Miller Investment Management's State Street SPDR S&P Biotech ETF position peaked at $1.14M in Q4 2020.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Miller Investment Management's 13F filing for Q1 2026, filed 8 May 2026.